Related Experiment Video
Updated: Jun 4, 2026

Application of Biochip Microfluidic Technology to Detect Serum Allergen-specific Immunoglobulin E (sIgE)
Published on: April 21, 2019
Using time-resolved fluorescence to measure serum venom-specific IgE and IgG
Pauline E van Eeden1, Michael D Wiese, Susan Aulfrey
1Centre for Clinical Research in Emergency Medicine, Western Australian Institute for Medical Research, University of Western Australia, Perth, Australia. Pauline.vaneeden@uwa.edu.au
Researchers adapted a DELFIA assay for quantifying specific IgE and IgG antibodies to Australian ant venoms, particularly jack jumper ant venom (JJAV). This method shows reliable accuracy and sensitivity for diagnosing ant venom allergies.
Area of Science:
- Immunology
- Allergy diagnostics
- Biochemical assays
Background:
- Australian native ant venoms, especially jack jumper ant venom (JJAV), are significant causes of allergic reactions.
- Accurate quantification of specific IgE (sIgE) and IgG subclasses (sIgG1, sIgG4) is crucial for diagnosing and managing ant venom allergies.
Purpose of the Study:
- To adapt the dissociation-enhanced lanthanide fluoroimmunoassay (DELFIA) for quantifying venom-specific IgE, IgG1, and IgG4 antibodies.
- To evaluate the performance of the adapted DELFIA assay for detecting JJAV-specific IgE compared to established methods and skin testing.
Main Methods:
- Adaptation of the DELFIA time-resolved fluorescence immunoassay.
- Quantification of whole venom and peptide-specific IgE, IgG1, and IgG4 in serum samples.
- Comparison of DELFIA results with Phadia CAP assay and intradermal skin testing for JJAV-specific IgE.
Main Results:
- The DELFIA assay demonstrated good intra-assay (6.3% CV) and inter-assay (13.7% CV) reproducibility for JJAV sIgE.
- DELFIA showed excellent correlation with Phadia CAP assay for JJAV sIgE.
- The sensitivity and specificity of DELFIA for detecting JJAV sIgE were comparable to intradermal skin testing.
Conclusions:
- The adapted DELFIA assay is a reliable and sensitive method for quantifying specific antibodies to Australian native ant venoms.
- DELFIA offers a viable alternative for diagnosing ant venom allergies, with potential for adaptation to other venom allergens.
More Related Videos
06:15Characterization of Thymus-dependent and Thymus-independent Immunoglobulin Isotype Responses in Mice Using Enzyme-linked Immunosorbent Assay
Published on: September 7, 2018
07:31Development of an in vitro model system for studying the interaction of Equus caballus IgE with its high-affinity receptor FcεRI
Published on: November 1, 2014